MARKET INSIGHT: PBM Specialty Pharmacy Industry 2018
As more pricing pressure builds, PBMS have maneuvered toward more transparent pricing models to appease regulators and customers despite IQVIA data proving that net brand price growth didn’t match the CPI for the first time in years. Of all PBM services, Medicare Part D and Medicaid have realized significant growth. Sharp increases in specialty drug prices should pay dividends to the greater specialty pharmacy market. Specialty drug spend has materially grown in retail and mail-order channels.
This Market Insight report also features relevant precedent transactions that have occurred in the recent past.
Read our 2017 Market Insight on the PBM Industry here.Click here to view this report in its entirety.